Literature DB >> 22789582

Treatment outcomes in congenital adrenal hyperplasia.

Tina Q Cheng1, Phyllis W Speiser.   

Abstract

Systematic literature review and meta-analysis guided by expert opinion has refined current approaches to the treatment of CAH. The advent of widespread newborn screening has improved outcomes, with lower morbidities and mortality. Future advances may be recognized in the form of more efficient diagnostic tools, physiologic drug delivery, improved surgical methods, and assisted reproductive technologies.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22789582     DOI： 10.1016/j.yapd.2012.04.009

Source DB:  PubMed          Journal:  Adv Pediatr        ISSN： 0065-3101


  2 in total

1.  Novel Use of Tolvaptan in a Pediatric Patient With Congestive Heart Failure Due to Duchenne Muscular Dystrophy and Congenital Adrenal Hyperplasia.

Authors:  Sarah A Sami; Brady S Moffett; Melissa L Karlsten; Antonio G Cabrera; Jack F Price; William J Dreyer; Susan W Denfield; Aamir Jeewa
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Sep-Oct

2.  The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts.

Authors:  Mirela Costa de Miranda; Luciana Bertocco de Paiva Haddad; Evelinda Trindade; Alex Cassenote; Giselle Y Hayashi; Durval Damiani; Fernanda Cavalieri Costa; Guiomar Madureira; Berenice Bilharinho de Mendonca; Tania A S S Bachega
Journal:  Front Pediatr       Date:  2021-05-24       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.